KEGG pathway analysis in liver microarrays suggested the induction of metabolic disorders, such as enrichment of glucagon signaling pathway, insulin resistance and adipocytokine signaling pathway, following A. actinomycetemcomitans administration. Here, GCG is linked to metabolic disease.